ELTX · Elicio Therapeutics Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 1.52 USD |
|---|---|
| 1-day change | -4.4% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 21 / 8 / 7 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 3 / 46 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +33.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +89.8% |
| Market cap (USD) | $218.0M |